Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378893106 | ||
| 003 | CHVBK | ||
| 005 | 20180305123500.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040205xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/BC.2004.036 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/BC.2004.036 | ||
| 245 | 0 | 0 | |a Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide |h [Elektronische Daten] |c [T. Walther, H. Stepan, K. Pankow, M. Becker, H.-P. Schultheiss, W.-E. Siems] |
| 520 | 3 | |a Recent reports presented contradictory results regarding the catabolism of mature atrial (ANP) and brain (BNP) natriuretic peptides in circulation. Especially the role of neutral endopeptidase (NEP) in BNP degradation was conversely discussed. Our present in vitro-studies characterize the NEP-dependent metabolism of ANP and BNP in different tissues via HPLC-analysis using NEP-deficient mice and specific NEP inhibitors. Our results show a strong tissue-dependent degradation pattern of both peptides, which are not only due to the different NEP activities in these tissues. Whereas NEP rapidly degraded ANP, it had no influence in BNP-metabolism. Additional experiments with purified NEP confirmed this result. Moreover, we describe a degradation of ANP and BNP in NEP-deficient and NEP-inhibited membranes. Consequently, we postulate the existence of at least one further natriuretic peptide (NP) degrading enzyme, which has not been characterized yet. Thus, the commonly accepted model of the natriuretic peptide system with NEP as the central degrading peptidase has to be partly revised. Moreover, the NEP-independent BNP degradation provides an effective means for achieving a beneficial BNP increase in cardiovascular pathology by inhibiting the assumed novel NP-degrading peptidase(s). | |
| 540 | |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG | ||
| 690 | 7 | |a Biochemistry |2 nationallicence | |
| 690 | 7 | |a Molecular biology |2 nationallicence | |
| 690 | 7 | |a Cellular biology |2 nationallicence | |
| 700 | 1 | |a Walther |D T. |4 aut | |
| 700 | 1 | |a Stepan |D H. |4 aut | |
| 700 | 1 | |a Pankow |D K. |4 aut | |
| 700 | 1 | |a Becker |D M. |4 aut | |
| 700 | 1 | |a Schultheiss |D H.-P |4 aut | |
| 700 | 1 | |a Siems |D W.-E |4 aut | |
| 773 | 0 | |t Biological Chemistry |d Walter de Gruyter |g 385/2(2004-02-05), 179-184 |x 1431-6730 |q 385:2<179 |1 2004 |2 385 |o bchm | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/BC.2004.036 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/BC.2004.036 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Walther |D T. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Stepan |D H. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Pankow |D K. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Becker |D M. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Schultheiss |D H.-P |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Siems |D W.-E |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Biological Chemistry |d Walter de Gruyter |g 385/2(2004-02-05), 179-184 |x 1431-6730 |q 385:2<179 |1 2004 |2 385 |o bchm | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||